更多...
收起
This gene encodes a member of the beta chemokine receptor family, which is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. This protein is expressed by T cells and macrophages, and is known to be an important co-receptor for macrophage-tropic virus, including HIV, to enter host cells. Defective alleles of this gene have been associated with the HIV infection resistance. The ligands of this receptor include monocyte chemoattractant protein 2 (MCP-2), macrophage inflammatory protein 1 alpha (MIP-1 alpha), macrophage inflammatory protein 1 beta (MIP-1 beta) and regulated on activation normal T expressed and secreted protein (RANTES). Expression of this gene was also detected in a promyeloblastic cell line, suggesting that this protein may play a role in granulocyte lineage proliferation and differentiation. This gene is located at the chemokine receptor gene cluster region. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
[中文简述(自动翻译):]  该基因编码的测试趋化因子受体家族,其被预测为类似于G蛋白偶联受体具有七次跨膜蛋白的成员。该蛋白质是由T细胞和巨噬细胞中表达,并且被称为是一个重要的共同受体为巨噬细胞热带病毒,包括HIV,进入宿主细胞。这种基因有缺陷的等位基因已与艾滋病毒感染的抵抗力有关。该受体的配体包括单核细胞趋化蛋白2(MCP-2),巨噬细胞炎性蛋白1α(MIP-1α),巨噬细胞炎性蛋白1β(MIP-1β)和调节活化正常T表达和分泌蛋白( RANTES)。在一个promyeloblastic细胞系也检测出该基因的表达,这表明该蛋白可能在粒细胞增殖和分化的作用。该基因位于趋化因子受体基因簇的区域。已发现了该基因编码的蛋白质相同的两个转录变异体。 [由RefSeq的,2008年7月提供]
CCR5基因(以及对应的蛋白质)的细胞分布位置:
CCR5基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
HIV Infections | 0.184519152 | 861 | 4 | BeFree_GAD_LHGDN |
Hepatitis C | 0.158739038 | 24 | 0 | BeFree_CTD_human_GAD_LHGDN |
IGA Glomerulonephritis | 0.130725648 | 3 | 0 | BeFree_CTD_human_GAD_LHGDN |
West Nile Fever | 0.124734064 | 2 | 0 | CTD_human_GAD |
Dermatitis, Atopic | 0.12 | 1 | 0 | CTD_human |
Nephritis | 0.12 | 1 | 0 | CTD_human |
Acute kidney injury | 0.12 | 1 | 0 | CTD_human |
DIABETES MELLITUS, INSULIN-DEPENDENT, 22 (disorder) | 0.12 | 0 | 0 | CTD_human |
Inflammation | 0.10367032 | 11 | 0 | GAD_RGD |
Diabetes Mellitus, Insulin-Dependent | 0.101922116 | 14 | 0 | BeFree_GAD_RGD |
Diabetes Mellitus, Non-Insulin-Dependent | 0.096645169 | 15 | 0 | BeFree_GAD_RGD |
Kidney Failure, Chronic | 0.096188161 | 8 | 0 | BeFree_GAD_LHGDN_RGD |
Alzheimer's Disease | 0.089468128 | 5 | 0 | GAD_RGD |
Coronary Artery Disease | 0.088458305 | 9 | 2 | BeFree_GAD_RGD |
Hypertensive disease | 0.085276948 | 5 | 0 | BeFree_GAD_RGD |
Brain Ischemia | 0.084734064 | 3 | 0 | GAD_RGD |
Uveitis | 0.082367032 | 2 | 0 | GAD_RGD |
Experimental Autoimmune Encephalomyelitis | 0.080542884 | 3 | 0 | BeFree_RGD |
Fever | 0.08 | 1 | 0 | RGD |
Hyperalgesia | 0.08 | 2 | 0 | RGD |
Myocardial Reperfusion Injury | 0.08 | 1 | 0 | RGD |
Orchitis | 0.08 | 1 | 0 | RGD |
Status Epilepticus | 0.08 | 1 | 0 | RGD |
Anterior uveitis | 0.08 | 1 | 0 | RGD |
Dermatitis, Allergic Contact | 0.08 | 1 | 0 | RGD |
Hypoxia-Ischemia, Brain | 0.08 | 1 | 0 | RGD |
Arthritis, Experimental | 0.08 | 2 | 0 | RGD |
Infection | 0.054487005 | 20 | 0 | LHGDN |
Multiple Sclerosis | 0.05419875 | 28 | 0 | BeFree_GAD_LHGDN |
Acquired Immunodeficiency Syndrome | 0.044568801 | 26 | 3 | BeFree_GAD_LHGDN |
Asthma | 0.039205977 | 20 | 0 | BeFree_GAD_LHGDN |
Rheumatoid Arthritis | 0.031985329 | 29 | 2 | BeFree_GAD_LHGDN |
Hepatitis C, Chronic | 0.019098077 | 12 | 0 | BeFree_GAD_LHGDN |
Hepatitis B | 0.017359805 | 11 | 0 | BeFree_GAD_LHGDN |
Diabetic Nephropathy | 0.017002487 | 10 | 1 | BeFree_GAD_LHGDN |
Myocardial Infarction | 0.013549688 | 8 | 1 | BeFree_GAD_LHGDN |
Graft-vs-Host Disease | 0.013006804 | 5 | 0 | BeFree_GAD_LHGDN |
HIV disease progression | 0.01183516 | 5 | 0 | GAD |
Atherosclerosis | 0.011725539 | 8 | 0 | BeFree_GAD_LHGDN |
Mucocutaneous Lymph Node Syndrome | 0.011182656 | 5 | 0 | BeFree_GAD_LHGDN |
Cardiovascular Diseases | 0.010911214 | 5 | 0 | BeFree_GAD_LHGDN |
Viremia | 0.010096888 | 5 | 0 | BeFree_GAD_LHGDN |
Hemophilia A | 0.009544073 | 11 | 0 | BeFree_GAD |
Juvenile arthritis | 0.009001189 | 7 | 0 | BeFree_GAD |
Lupus Nephritis | 0.0089015 | 5 | 0 | BeFree_GAD_LHGDN |
Coronary heart disease | 0.008815624 | 6 | 0 | BeFree_GAD_LHGDN |
Chagas Disease | 0.008815624 | 5 | 0 | BeFree_GAD_LHGDN |
Cholangitis, Sclerosing | 0.008544182 | 4 | 0 | BeFree_GAD_LHGDN |
Sarcoidosis | 0.008544182 | 5 | 0 | BeFree_GAD_LHGDN |
Aortic Aneurysm, Abdominal | 0.008001298 | 2 | 0 | BeFree_GAD_LHGDN |
Arterial Occlusive Diseases | 0.007729856 | 2 | 0 | BeFree_GAD_LHGDN |
Sarcoidosis, Pulmonary | 0.007729856 | 3 | 0 | BeFree_GAD_LHGDN |
Chlamydia Infections | 0.007372538 | 3 | 0 | BeFree_GAD |
Pregnancy Complications, Infectious | 0.007101096 | 3 | 0 | GAD |
Inflammatory Bowel Diseases | 0.006905599 | 8 | 2 | BeFree_GAD |
Behcet Syndrome | 0.00617715 | 4 | 0 | BeFree_GAD_LHGDN |
Coronary Arteriosclerosis | 0.005819831 | 5 | 0 | BeFree_GAD |
Crohn Disease | 0.005819831 | 4 | 0 | BeFree_GAD |
Chronic Obstructive Airway Disease | 0.005634266 | 3 | 0 | BeFree_GAD_LHGDN |
Mammary Neoplasms | 0.005634266 | 4 | 0 | BeFree_GAD_LHGDN |
Cervix carcinoma | 0.00554839 | 3 | 0 | BeFree_GAD |
Adenocarcinoma | 0.0054487 | 2 | 0 | LHGDN |
Prostatic Neoplasms | 0.0054487 | 2 | 0 | LHGDN |
Brucellosis | 0.005362824 | 1 | 0 | BeFree_GAD_LHGDN |
Schizophrenia | 0.005362824 | 2 | 0 | BeFree_GAD_LHGDN |
Cerebrovascular accident | 0.005276948 | 3 | 3 | BeFree_GAD |
melanoma | 0.005091382 | 1 | 0 | GAD_LHGDN |
Disease Progression | 0.005091382 | 2 | 0 | GAD_LHGDN |
Anemia, Sickle Cell | 0.005005506 | 2 | 0 | BeFree_GAD |
Carotid Stenosis | 0.005005506 | 2 | 0 | BeFree_GAD |
Chagas Cardiomyopathy | 0.005005506 | 2 | 0 | BeFree_GAD |
Carotid Artery Diseases | 0.004734064 | 2 | 0 | GAD |
Celiac Disease | 0.004734064 | 2 | 1 | GAD |
Plague | 0.004734064 | 2 | 0 | GAD |
Respiratory Syncytial Virus Infections | 0.004734064 | 2 | 0 | GAD |
Substance Abuse, Intravenous | 0.004734064 | 2 | 0 | GAD |
Bronchial Hyperreactivity | 0.004734064 | 2 | 0 | GAD |
Hematologic Neoplasms | 0.004734064 | 2 | 0 | GAD |
Hepatitis B, Chronic | 0.004734064 | 2 | 0 | GAD |
Arthritis | 0.004267125 | 7 | 0 | BeFree_GAD |
Malignant neoplasm of breast | 0.004267125 | 7 | 0 | BeFree_GAD |
Virus Diseases | 0.004071628 | 15 | 0 | BeFree |
Lupus Erythematosus, Systemic | 0.003995683 | 6 | 0 | BeFree_GAD |
Malignant neoplasm of prostate | 0.003995683 | 6 | 0 | BeFree_GAD |
Encephalitis | 0.003810118 | 4 | 0 | BeFree_LHGDN |
Liver diseases | 0.003538676 | 4 | 0 | BeFree_LHGDN |
Lichen Planus, Oral | 0.003538676 | 3 | 0 | BeFree_LHGDN |
Liver carcinoma | 0.003452799 | 4 | 0 | BeFree_GAD |
Multiple Myeloma | 0.003267234 | 3 | 0 | BeFree_LHGDN |
Superinfection | 0.003267234 | 3 | 0 | BeFree_LHGDN |
hiv-infection/aids | 0.003257302 | 12 | 0 | BeFree |
Bronchiolitis | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Hyperlipidemia | 0.002995792 | 1 | 0 | BeFree_LHGDN |
leukemia | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Lung diseases | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Myositis | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Vasculitis | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Renal Insufficiency | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Malignant neoplasm of urinary bladder | 0.002909916 | 3 | 1 | BeFree_GAD |
Cytomegalovirus Infections | 0.002909916 | 3 | 0 | BeFree_GAD |
Tick-Borne Encephalitis | 0.002909916 | 3 | 2 | BeFree_GAD |
Liver Cirrhosis | 0.002909916 | 2 | 0 | BeFree_GAD |
Lymphoma | 0.002909916 | 3 | 0 | BeFree_GAD |
Periodontitis | 0.002909916 | 2 | 0 | BeFree_GAD |
Arthritis, Reactive | 0.002909916 | 2 | 0 | BeFree_GAD |
Malignant neoplasm of pancreas | 0.002909916 | 2 | 0 | BeFree_GAD |
Pneumocystis jiroveci pneumonia | 0.002909916 | 2 | 0 | BeFree_GAD |
Colorectal Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
Lymphocytic Choriomeningitis | 0.00272435 | 1 | 0 | LHGDN |
Optic Neuritis | 0.00272435 | 1 | 0 | LHGDN |
Arthritis, Psoriatic | 0.002638474 | 1 | 0 | BeFree_GAD |
Transient Ischemic Attack | 0.002638474 | 1 | 0 | BeFree_GAD |
Coronary Aneurysm | 0.002638474 | 1 | 0 | BeFree_GAD |
Cryptosporidiosis | 0.002638474 | 1 | 0 | BeFree_GAD |
Herpes zoster disease | 0.002638474 | 1 | 0 | BeFree_GAD |
Meningoencephalitis | 0.002638474 | 1 | 0 | BeFree_GAD |
Mycobacterium avium-intracellulare Infection | 0.002638474 | 1 | 0 | BeFree_GAD |
Polymyalgia Rheumatica | 0.002638474 | 2 | 0 | BeFree_GAD |
Toxoplasmosis | 0.002638474 | 2 | 0 | BeFree_GAD |
Vitiligo | 0.002638474 | 1 | 0 | BeFree_GAD |
Epstein-Barr Virus Infections | 0.002638474 | 2 | 0 | BeFree_GAD |
Neoplasm, Residual | 0.002638474 | 1 | 0 | BeFree_GAD |
Cancer of Head and Neck | 0.002638474 | 1 | 0 | BeFree_GAD |
Mucocutaneous leishmaniasis | 0.002638474 | 1 | 0 | BeFree_GAD |
Hemophilia, NOS | 0.002442977 | 9 | 0 | BeFree |
Aortic Valve Stenosis | 0.002367032 | 1 | 0 | GAD |
Berylliosis | 0.002367032 | 1 | 0 | GAD |
Biliary Tract Diseases | 0.002367032 | 1 | 0 | GAD |
Brain Neoplasms | 0.002367032 | 1 | 0 | GAD |
Bronchiolitis, Viral | 0.002367032 | 1 | 0 | GAD |
Chromosome Deletion | 0.002367032 | 1 | 0 | GAD |
Cross Infection | 0.002367032 | 1 | 0 | GAD |
Embolism | 0.002367032 | 1 | 0 | GAD |
Erythema Nodosum | 0.002367032 | 1 | 0 | GAD |
Female Genital Diseases | 0.002367032 | 1 | 0 | GAD |
Delayed Hypersensitivity | 0.002367032 | 1 | 0 | GAD |
Immediate hypersensitivity | 0.002367032 | 1 | 0 | GAD |
Hypertension, Portal | 0.002367032 | 1 | 0 | GAD |
Female infertility | 0.002367032 | 1 | 0 | GAD |
Ischemia | 0.002367032 | 1 | 0 | GAD |
Laryngeal neoplasm | 0.002367032 | 1 | 0 | GAD |
Leishmaniasis, Cutaneous | 0.002367032 | 1 | 0 | GAD |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.002367032 | 1 | 0 | GAD |
Biliary cirrhosis | 0.002367032 | 1 | 0 | GAD |
Liver neoplasms | 0.002367032 | 1 | 0 | GAD |
Animal Mammary Neoplasms | 0.002367032 | 1 | 0 | GAD |
Neoplasm Recurrence, Local | 0.002367032 | 1 | 0 | GAD |
Nephrotic Syndrome | 0.002367032 | 1 | 0 | GAD |
Occupational Diseases | 0.002367032 | 1 | 0 | GAD |
Postoperative Complications | 0.002367032 | 1 | 0 | GAD |
Rheumatism | 0.002367032 | 1 | 0 | GAD |
Skin Neoplasms | 0.002367032 | 1 | 0 | GAD |
Thyroid Neoplasm | 0.002367032 | 1 | 0 | GAD |
Trachoma | 0.002367032 | 1 | 0 | GAD |
Diffuse Large B-Cell Lymphoma | 0.002367032 | 1 | 0 | GAD |
Left Ventricular Hypertrophy | 0.002367032 | 1 | 0 | GAD |
Aneurysm, Ruptured | 0.002367032 | 1 | 0 | GAD |
Renal transplant rejection | 0.002367032 | 1 | 0 | GAD |
Malignant neoplasm of lung | 0.002367032 | 1 | 0 | GAD |
Restenosis | 0.002367032 | 1 | 0 | GAD |
Human immunodeficiency virus leukoencephalopathy | 0.002367032 | 1 | 0 | GAD |
Pregnancy loss | 0.002367032 | 1 | 0 | GAD |
Acute Coronary Syndrome | 0.002367032 | 1 | 0 | GAD |
Coronary Restenosis | 0.002367032 | 1 | 0 | GAD |
Systemic arterial pressure | 0.002367032 | 1 | 0 | GAD |
Sjogren's Syndrome | 0.002367032 | 1 | 0 | GAD |
Venous Thromboembolism | 0.002367032 | 1 | 0 | GAD |
HIV-1 infection | 0.002367032 | 1 | 0 | GAD |
Chronic ulcerative colitis | 0.002367032 | 1 | 0 | GAD |
Granulomatosis with polyangiitis | 0.002367032 | 1 | 0 | GAD |
Mitral Valve Stenosis | 0.002171535 | 8 | 0 | BeFree |
Neoplasm Metastasis | 0.002171535 | 8 | 0 | BeFree |
Juvenile rheumatoid arthritis | 0.002171535 | 8 | 0 | BeFree |
Arteriosclerosis | 0.001900093 | 7 | 0 | BeFree |
Breast Carcinoma | 0.001900093 | 7 | 0 | BeFree |
Kidney Diseases | 0.001628651 | 6 | 0 | BeFree |
Prostate carcinoma | 0.001628651 | 6 | 0 | BeFree |
West Nile viral infection | 0.001628651 | 6 | 0 | BeFree |
Colorectal Carcinoma | 0.001357209 | 5 | 0 | BeFree |
Herpes Simplex Infections | 0.001357209 | 5 | 0 | BeFree |
Tuberculosis, Pulmonary | 0.001357209 | 5 | 0 | BeFree |
Primary infection NOS | 0.001357209 | 5 | 0 | BeFree |
Colorectal Cancer | 0.001357209 | 5 | 0 | BeFree |
Ulcerative Colitis | 0.001085767 | 4 | 1 | BeFree |
Immunologic Deficiency Syndromes | 0.001085767 | 4 | 0 | BeFree |
Influenza | 0.001085767 | 4 | 0 | BeFree |
Kidney Failure | 0.001085767 | 4 | 0 | BeFree |
Tuberculosis | 0.001085767 | 4 | 0 | BeFree |
Chronic kidney disease stage 5 | 0.001085767 | 4 | 2 | BeFree |
AIDS Dementia Complex | 0.000814326 | 3 | 0 | BeFree |
Malignant tumor of cervix | 0.000814326 | 3 | 0 | BeFree |
Glioblastoma | 0.000814326 | 3 | 0 | BeFree |
Malaria | 0.000814326 | 3 | 0 | BeFree |
Degenerative polyarthritis | 0.000814326 | 3 | 0 | BeFree |
Giant Cell Arteritis | 0.000814326 | 3 | 0 | BeFree |
Malignant neoplasm of mouth | 0.000814326 | 3 | 0 | BeFree |
Lip and Oral Cavity Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Human immunodeficiency virus, type 2 [HIV-2] infection in conditions classified elsewhere and of unspecified site | 0.000814326 | 3 | 0 | BeFree |
Primary sclerosing cholangitis | 0.000814326 | 3 | 0 | BeFree |
Cardiomyopathies | 0.000814326 | 3 | 0 | BeFree |
Astrocytoma | 0.000542884 | 2 | 0 | BeFree |
Primary biliary cirrhosis | 0.000542884 | 2 | 0 | BeFree |
Dengue Fever | 0.000542884 | 2 | 0 | BeFree |
Diabetes | 0.000542884 | 2 | 0 | BeFree |
Diabetes Mellitus | 0.000542884 | 2 | 0 | BeFree |
Heart failure | 0.000542884 | 2 | 0 | BeFree |
Congestive heart failure | 0.000542884 | 2 | 0 | BeFree |
Leishmaniasis | 0.000542884 | 2 | 0 | BeFree |
nervous system disorder | 0.000542884 | 2 | 0 | BeFree |
Obesity | 0.000542884 | 2 | 0 | BeFree |
Opportunistic Infections | 0.000542884 | 2 | 0 | BeFree |
Psoriasis | 0.000542884 | 2 | 0 | BeFree |
Vascular Diseases | 0.000542884 | 2 | 0 | BeFree |
Severe Combined Immunodeficiency | 0.000542884 | 2 | 0 | BeFree |
Active tuberculosis | 0.000542884 | 2 | 0 | BeFree |
Primary Sj�gren's syndrome | 0.000542884 | 2 | 0 | BeFree |
Allergic asthma | 0.000542884 | 2 | 0 | BeFree |
Tumor Progression | 0.000542884 | 2 | 0 | BeFree |
Pancreatic carcinoma | 0.000542884 | 2 | 0 | BeFree |
Coinfection | 0.000542884 | 2 | 0 | BeFree |
Bubonic Plague | 0.000542884 | 2 | 0 | BeFree |
Superficial ulcer | 0.000542884 | 2 | 0 | BeFree |
Infective vaginitis | 0.000542884 | 2 | 0 | BeFree |
Granulomatosis | 0.000542884 | 2 | 0 | BeFree |
Metabolic Syndrome X | 0.000542884 | 2 | 0 | BeFree |
Carcinoma of bladder | 0.000542884 | 2 | 1 | BeFree |
Bone Diseases | 0.000271442 | 1 | 0 | BeFree |
Malignant tumor of colon | 0.000271442 | 1 | 0 | BeFree |
CNS disorder | 0.000271442 | 1 | 0 | BeFree |
Chondrosarcoma | 0.000271442 | 1 | 0 | BeFree |
Choriocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Cystic Fibrosis | 0.000271442 | 1 | 0 | BeFree |
Presenile dementia | 0.000271442 | 1 | 0 | BeFree |
Down Syndrome | 0.000271442 | 1 | 0 | BeFree |
Dry Eye Syndromes | 0.000271442 | 1 | 0 | BeFree |
Endometriosis | 0.000271442 | 1 | 1 | BeFree |
Gaucher Disease | 0.000271442 | 1 | 0 | BeFree |
Gingival Diseases | 0.000271442 | 1 | 0 | BeFree |
Glioma | 0.000271442 | 1 | 0 | BeFree |
Graves Disease | 0.000271442 | 1 | 0 | BeFree |
Hodgkin Disease | 0.000271442 | 1 | 0 | BeFree |
Arthropathy | 0.000271442 | 1 | 0 | BeFree |
Acute Kidney Tubular Necrosis | 0.000271442 | 1 | 0 | BeFree |
Leukemia, Myelocytic, Acute | 0.000271442 | 1 | 0 | BeFree |
Lymphoma, Follicular | 0.000271442 | 1 | 0 | BeFree |
Measles | 0.000271442 | 1 | 0 | BeFree |
Mouth Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Mycoses | 0.000271442 | 1 | 0 | BeFree |
Nephritis, Interstitial | 0.000271442 | 1 | 0 | BeFree |
Neuroblastoma | 0.000271442 | 1 | 0 | BeFree |
Osteomyelitis | 0.000271442 | 1 | 0 | BeFree |
Osteosarcoma | 0.000271442 | 1 | 0 | BeFree |
Pancreatic Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Periodontal Diseases | 0.000271442 | 1 | 0 | BeFree |
Pulmonary Edema | 0.000271442 | 1 | 0 | BeFree |
Retinal Detachment | 0.000271442 | 1 | 0 | BeFree |
Sexually Transmitted Diseases | 0.000271442 | 1 | 0 | BeFree |
Smallpox | 0.000271442 | 1 | 0 | BeFree |
Synovitis | 0.000271442 | 1 | 0 | BeFree |
Syphilis | 0.000271442 | 1 | 0 | BeFree |
Tetanus | 0.000271442 | 1 | 0 | BeFree |
Yellow Fever | 0.000271442 | 1 | 0 | BeFree |
Lymphoma, AIDS-Related | 0.000271442 | 1 | 0 | BeFree |
Acute leukemia | 0.000271442 | 1 | 0 | BeFree |
Genital ulceration | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma of lung (disorder) | 0.000271442 | 1 | 0 | BeFree |
Joint swelling | 0.000271442 | 1 | 0 | BeFree |
Idiopathic pulmonary hypertension | 0.000271442 | 1 | 0 | BeFree |
Systemic candidiasis | 0.000271442 | 1 | 0 | BeFree |
Secondary malignant neoplasm of lung | 0.000271442 | 1 | 0 | BeFree |
Secondary malignant neoplasm of bone | 0.000271442 | 1 | 0 | BeFree |
Infections specific to perinatal period | 0.000271442 | 1 | 0 | BeFree |
Chronic berylliosis | 0.000271442 | 1 | 0 | BeFree |
Morning stiffness (>1 hour) | 0.000271442 | 1 | 0 | BeFree |
pediatric AIDS | 0.000271442 | 1 | 0 | BeFree |
Mucosa-Associated Lymphoid Tissue Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Parasitemia | 0.000271442 | 1 | 0 | BeFree |
Ichthyosis linearis circumflexa | 0.000271442 | 1 | 0 | BeFree |
Vesicular Stomatitis | 0.000271442 | 1 | 0 | BeFree |
Metastatic melanoma | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma of pancreas | 0.000271442 | 1 | 0 | BeFree |
Rocio virus encephalitis | 0.000271442 | 1 | 0 | BeFree |
Chronic liver disease | 0.000271442 | 1 | 0 | BeFree |
Asymptomatic human immunodeficiency virus infection | 0.000271442 | 1 | 0 | BeFree |
Disseminated Malignant Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site | 0.000271442 | 1 | 0 | BeFree |
Idiopathic crescentic glomerulonephritis | 0.000271442 | 1 | 0 | BeFree |
Neuropathy | 0.000271442 | 1 | 0 | BeFree |
Dementia | 0.000271442 | 1 | 0 | BeFree |
Osteosarcoma of bone | 0.000271442 | 1 | 0 | BeFree |
Biliary stricture | 0.000271442 | 1 | 0 | BeFree |
Terminal illness | 0.000271442 | 1 | 0 | BeFree |
Colon Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Central neuroblastoma | 0.000271442 | 1 | 0 | BeFree |
AIDS defining illness | 0.000271442 | 1 | 0 | BeFree |
infertility tubal factor | 0.000271442 | 1 | 0 | BeFree |
lung disease granulomatous | 0.000271442 | 1 | 0 | BeFree |
Acute GVH disease | 0.000271442 | 1 | 0 | BeFree |
Metastatic Prostate Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Colorectal cancer metastatic | 0.000271442 | 1 | 0 | BeFree |
Primary HIV infection | 0.000271442 | 1 | 0 | BeFree |
Squamous cell carcinoma of the head and neck | 0.000271442 | 1 | 0 | BeFree |
Inflammatory disorder | 0.000271442 | 1 | 0 | BeFree |
Aggressive natural killer-cell leukemia | 0.000271442 | 1 | 0 | BeFree |
Peripheral arterial occlusive disease | 0.000271442 | 1 | 0 | BeFree |
Pediatric human immunodeficiency virus infection | 0.000271442 | 1 | 0 | BeFree |
Neuropathogenesis | 0.000271442 | 1 | 0 | BeFree |
Tumor Angiogenesis | 0.000271442 | 1 | 0 | BeFree |
Ocular surface disease | 0.000271442 | 1 | 0 | BeFree |
Non-Malignant Ascites Adverse Event | 0.000271442 | 1 | 0 | BeFree |
Upper urinary tract infection | 0.000271442 | 1 | 0 | BeFree |
MULTICYSTIC RENAL DYSPLASIA, BILATERAL | 0.000271442 | 1 | 0 | BeFree |
Pulmonary arterial hypertension | 0.000271442 | 1 | 0 | BeFree |
Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia | 0.000271442 | 1 | 0 | BeFree |
Flaviviral diseases | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。